Scinovex
review Open AccessTop 10% cited

Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis

PLoS Medicine · 2012 · Vol. 9(8) · pp. e1001293–e1001293
Jicheng LvBruce NealParya EhteshamiToshiharu NinomiyaMark WoodwardAnthony RodgersHaiyan WangStephen MacMahonFiona TurnbullGraham S. HillisJohn ChalmersVlado Perkovic

Abstract

Intensive BP lowering regimens provided greater vascular protection than standard regimens that was proportional to the achieved difference in systolic BP, but did not have any clear impact on the risk of death or serious adverse events. Further trials are required to more clearly define the risks and benefits of BP targets below those currently recommended, given the benefits suggested by the currently available data.

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease PreventionCardiovascular Syncope and Autonomic DisordersMedicineBlood pressureStroke (engine)Myocardial infarctionInternal medicineMeta-analysisIntensive careRelative riskAlbuminuriaPlacebo

MeSH terms

Antihypertensive AgentsBlood PressureCardiovascular DiseasesCardiovascular SystemClinical Trials as TopicHumansKidneyKidney DiseasesRegression AnalysisRisk FactorsTreatment Outcome

Funding

  • Amgen
  • Pfizer
  • Servier
  • Medical Research Council
  • National Health and Medical Research Council
Citations
778
FWCI
6.83
field-weighted impact
References
81
Percentile
98%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.